Optimisation of bioluminescent reporters for use with mycobacteria

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Andreu, Nuria ^a   Zelmer, Andrea ^b   Fletcher, Taryn ^a   Elkington, Paul T ^a   Ward, Theresa H ^b   Ripoll, Jorge ^c   Parish, Tanya ^d,e   Bancroft, Gregory J ^b   Schaible, Ulrich ^b,f   Robertson, Brian D ^a   Wiles, Siouxsie ^b,g  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c INSTITUTE OF ELECTRONIC STRUCTURE AND LASER   (Greece)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e Infectious Diseases Research Institute   (United States)

^f RESEARCH CENTER BORSTEL   (Germany)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HEAT SHOCK PROTEIN 60; LUCIFERASE; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIUM DETECTION; BIOLUMINESCENCE; CODON; CONTROLLED STUDY; ENZYME LOCALIZATION; ENZYME RELEASE; ENZYME SUBSTRATE; EXPRESSION VECTOR; FEMALE; FIREFLY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; MOUSE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; PROMOTER REGION; PROTEIN EXPRESSION; REACTION OPTIMIZATION; SIGNAL DETECTION; SIGNAL NOISE RATIO;

ANIMALS; CODON; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; IMAGING, THREE-DIMENSIONAL; KINETICS; LUCIFERASES; LUMINESCENT PROTEINS; MICE; MYCOBACTERIUM SMEGMATIS; WHOLE BODY IMAGING;

ANIMALIA; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 77956534319     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010777     Document Type: Article

References (76)

1. WHO (2009) Global tuberculosis control 2009. Epidemiology, strategy, financing: WHO Press. 303 p.
2. Hutchens M, Luker GD (2007) Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 9: 2315-2322.
3. Wright JS, 3rd, Jin R, Novick RP (2005) Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci USA 102: 1691-1696.
4. Lane MC, Alteri CJ, Smith SN, Mobley HL (2007) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci USA 104: 16669-16674.
5. Steinhuber A, Landmann R, Goerke C, Wolz C, Fluckiger U (2008) Bioluminescence imaging to study the promoter activity of hla of Staphylococcus aureus in vitro and in vivo. Int J Med Microbiol 298: 599-605.
6. Xiong YQ, Willard J, Kadurugamuwa JL, Yu J, Francis KP, et al. (2005) Realtime in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model. Antimicrob Agents Chemother 49: 380-387.
7. Kadurugamuwa JL, Modi K, Yu J, Francis KP, Orihuela C, et al. (2005) Noninvasive monitoring of pneumococcal meningitis and evaluation of treatment efficacy in an experimental mouse model. Mol Imaging 4: 137-142.
8. Gheysens O, Mottaghy FM (2009) Method of bioluminescence imaging for molecular imaging of physiological and pathological processes. Methods 48: 139-145.
9. Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11: 435-443.
10. Wiles S, Ferguson K, Stefanidou M, Young DB, Robertson BD (2005) Alternative luciferase for monitoring bacterial cells under adverse conditions. Appl Environ Microbiol 71: 3427-3432.
11. Prioli RP, Tanna A, Brown IN (1985) Rapid methods for counting mycobacteria-comparison of methods for extraction of mycobacterial adenosine triphosphate (ATP) determined by firefly luciferase assay. Tubercle 66: 99-108.
12. Janaszek W, Aleksandrowicz J, Sitkiewicz D (1987) The use of the firefly bioluminescent reaction for the rapid detection and counting of mycobacterium BCG. J Biol Stand 15: 11-16.
13. Andrew PW, Roberts IS (1993) Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents. J Clin Microbiol 31: 2251-2254.
14. Cooksey RC, Crawford JT, Jacobs WR, Jr., Shinnick TM (1993) A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother 37: 1348-1352.
15. Cooksey RC, Morlock GP, Beggs M, Crawford JT (1995) Bioluminescence method to evaluate antimicrobial agents against Mycobacterium avium. Antimicrob Agents Chemother 39: 754-756.
16. Arain TM, Resconi AE, Hickey MJ, Stover CK (1996) Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery. Antimicrob Agents Chemother 40: 1536-1541.
17. Gordon S, Chung G, Andrew P (1998) The application of bacterial luciferase as a reporter gene in mycobacteria. Methods Mol Biol 101: 235-243.
18. Deb DK, Srivastava KK, Srivastava R, Srivastava BS (2000) Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages. Biochem Biophys Res Commun 279: 457-461.
19. Shawar RM, Humble DJ, Van Dalfsen JM, Stover CK, Hickey MJ, et al. (1997) Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrob Agents Chemother 41: 570-574.
20. Jacobs WR, Jr., Barletta RG, Udani R, Chan J, Kalkut G, et al. (1993) Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260: 819-822.
21. Carriere C, Riska PF, Zimhony O, Kriakov J, Bardarov S, et al. (1997) Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 35: 3232-3239.
22. Riska PF, Jacobs WR, Jr., Bloom BR, McKitrick J, Chan J (1997) Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J Clin Microbiol 35: 3225-3231.
23. Riska PF, Jacobs WR, Jr. (1998) The use of luciferase-reporter phage for antibiotic-susceptibility testing of mycobacteria. Methods Mol Biol 101: 431-455.
24. Banaiee N, Bobadilla-Del-Valle M, Bardarov S, Jr., Riska PF, Small PM, et al. (2001) Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol 39: 3883-3888.
25. Bardarov S, Jr., Dou H, Eisenach K, Banaiee N, Ya S, et al. (2003) Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system. Diagn Microbiol Infect Dis 45: 53-61.
26. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL (2005) Bacteriophagebased assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 51: 175-187.
27. Banaiee N, January V, Barthus C, Lambrick M, Roditi D, et al. (2008) Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa. Tuberculosis (Edinb) 88: 64-68.
28. Arain TM, Resconi AE, Singh DC, Stover CK (1996) Reporter gene technology to assess activity of antimycobacterial agents in macrophages. Antimicrob Agents Chemother 40: 1542-1544.
29. Hickey MJ, Arain TM, Shawar RM, Humble DJ, Langhorne MH, et al. (1996) Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob Agents Chemother 40: 400-407.
30. Bonay M, Bouchonnet F, Pelicic V, Lagier B, Grandsaigne M, et al. (1999) Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strain. Am J Respir Crit Care Med 159: 1629-1637.
31. Snewin VA, Gares MP, Gaora PO, Hasan Z, Brown IN, et al. (1999) Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect Immun 67: 4586-4593.
32. Bouchonnet F, Boechat N, Bonay M, Hance AJ (2002) Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect Immun 70: 3020-3025.
33. Turner DJ, Hoyle SL, Snewin VA, Gares MP, Brown IN, et al. (2002) An ex vivo culture model for screening drug activity against in vivo phenotypes of Mycobacterium tuberculosis. Microbiology 148: 2929-2936.
34. Kampmann B, Tena GN, Mzazi S, Eley B, Young DB, et al. (2004) Novel human in vitro system for evaluating antimycobacterial vaccines. Infect Immun 72: 6401-6407.
35. Al-Attiyah R, El-Shazly A, Mustafa AS (2006) Assessment of in vitro immunity to Mycobacterium tuberculosis in a human peripheral blood infection model using a luciferase reporter construct of M. tuberculosis H37Rv. Clin Exp Immunol 145: 520-527.
36. Heuts F, Carow B, Wigzell H, Rottenberg ME (2009) Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity. Micro Infect 11: 1114-1121.
37. Ranes MG, Rauzier J, Lagranderie M, Gheorghiu M, Gicquel B (1990) Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a "mini" mycobacterium-Escherichia coli shuttle vector. J Bacteriol 172: 2793-2797.
38. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, et al. (1991) New use of BCG for recombinant vaccines. Nature 351: 456-460.
39. Carroll P, Schreuder LJ, Muwanguzi-Karugaba J, Wiles S, Robertson BD, et al. (2010) Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red Reporters. PLoS One 5: e9823. doi:10.1371/journal.pone.0009823.
40. Bourn WR, Jansen Y, Stutz H, Warren RM, Williamson AL, et al. (2007) Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial replicon. Tuberculosis (Edinb) 87: 481-488.
41. Qazi SN, Counil E, Morrissey J, Rees CE, Cockayne A, et al. (2001) agr expression precedes escape of internalized Staphylococcus aureus from the host endosome. Infect Immun 69: 7074-7082.
42. Ehrt S, Guo XV, Hickey CM, Ryou M, Monteleone M, et al. (2005) Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res 33: e21.
43. Barker LP, Porcella SF, Wyatt RG, Small PL (1999) The Mycobacterium marinum G13 promoter is a strong sigma 70-like promoter that is expressed in Escherichia coli and mycobacteria species. FEMS Microbiol Lett 175: 79-85.
44. Barker LP, Brooks DM, Small PL (1998) The identification of Mycobacterium marinum genes differentially expressed in macrophage phagosomes using promoter fusions to green fluorescent protein. Mol Microbiol 29: 1167-1177.
45. Le Dantec C, Winter N, Gicquel B, Vincent V, Picardeau M (2001) Genomic sequence and transcriptional analysis of a 23-kilobase mycobacterial linear plasmid: evidence for horizontal transfer and identification of plasmid maintenance systems. J Bacteriol 183: 2157-2164.
46. Craney A, Hohenauer T, Xu Y, Navani NK, Li Y, et al. (2007) A synthetic luxCDABE gene cluster optimized for expression in high-GC bacteria. Nucleic Acids Res 35: e46.
47. Zhao H, Doyle TC, Wong RJ, Cao Y, Stevenson DK, et al. (2004) Characterization of coelenterazine analogs for measurements of Renilla luciferase activity in live cells and living animals. Mol Imaging 3: 43-54.
48. Davis SL, Be NA, Lamichhane G, Nimmagadda S, Pomper MG, et al. (2009) Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals. PLoS ONE 4: e6297.
49. Hardy J, Francis KP, DeBoer M, Chu P, Gibbs K, et al. (2004) Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303: 851-853.
50. Kadurugamuwa JL, Modi K, Coquoz O, Rice B, Smith S, et al. (2005) Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response. Infect Immun 73: 7836-7843.
51. Wiles S, Pickard KM, Peng K, MacDonald TT, Frankel G (2006) In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun 74: 5391-5396.
52. Glomski IJ, Piris-Gimenez A, Huerre M, Mock M, Goossens PL (2007) Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 3: e76.
53. Lane MC, Alteri CJ, Smith SN, Mobley HL (2007) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci USA 104: 16669-16674.
54. Sjolinder H, Jonsson AB (2007) Imaging of disease dynamics during meningococcal sepsis. PLoS ONE 2: e241.
55. Kong D, Kunimoto DY (1995) Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG. Infect Immun 63: 799-803.
56. Mederle I, Bourguin I, Ensergueix D, Badell E, Moniz-Peireira J, et al. (2002) Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responses. Infect Immun 70: 303-314.
57. Kumar D, Srivastava BS, Srivastava R (1998) Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli beta-galactosidase in Mycobacterium smegmatis and its implication in vaccine development. Vaccine 16: 1212-1215.
58. Dennehy M, Bourn W, Steele D, Williamson AL (2007) Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. Vaccine 25: 3646-3657.
59. Dennehy M, Williamson AL (2005) Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine 23: 1209-1224.
60. Bastos RG, Dellagostin OA, Barletta RG, Doster AR, Nelson E, et al. (2002) Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus. Vaccine 21: 21-29.
61. da Cruz FW, McBride AJ, Conceicao FR, Dale JW, McFadden J, et al. (2001) Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in Mycobacterium bovis BCG and induction of an humoral response in mice. Vaccine 20: 731-736.
62. Dellagostin OA, Esposito G, Eales LJ, Dale JW, McFadden J (1995) Activity of mycobacterial promoters during intracellular and extracellular growth. Microbiology 141 (Pt 8): 1785-1792.
63. Wang H, Liu Q, Liu K, Zhong W, Gao S, et al. (2007) Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 56: 263-268.
64. Szittner R, Jansen G, Thomas DY, Meighen E (2003) Bright stable luminescent yeast using bacterial luciferase as a sensor. Biochem Biophys Res Commun 309: 66-70.
65. Buckley SM, Howe SJ, Rahim AA, et al. (2008) Luciferin detection after intranasal vector delivery is improved by intranasal rather than intraperitoneal luciferin administration. Hum Gene Ther 19: 1050-1056.
66. Wurdinger T, Badr C, Pike L, de Kleine R, Weissleder R, et al. (2008) A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 5: 171-173.
67. Loimaranta V, Tenovuo J, Koivisto L, Karp M (1998) Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds. Antimicrob Agents Chemother 42: 1906-1910.
68. Francis KP, Yu J, Bellinger-Kawahara C, et al. (2001) Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumoniae transformed with a novel gram-positive lux transposon. Infect Immun 69: 3350-3358.
69. Koga K, Harada T, Shimizu H, Tanaka K (2005) Bacterial luciferase activity and the intracellular redox pool in Escherichia coli. Mol Genet Genomics 274: 180-188.
70. Galluzzi L, Karp M (2007) Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. J Biotechnol 127: 188-198.
71. Morin CE, Kaper JB (2009) Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103- HgR. FEMS Immunology & Medical Microbiology 57: 69-79.
72. Snapper SB, Melton RE, Mustafa S, Kieser T, Jacobs WR, Jr. (1990) Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4: 1911-1919.
73. Parish T, Stoker NG (1998) Electroporation of mycobacteria. Methods Mol Biol 101: 129-144.
74. Bivas-Benita M, Zwier R, Junginger HE, Borchard G (2005) Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. European Journal of Pharmaceutics and Biopharmaceutics 61: 214-218.
75. Garbe TR, Barathi J, Barnini S, Zhang Y, Abou-Zeid C, et al. (1994) Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140 (Pt 1): 133-138.
76. Guo XV, Monteleone M, Klotzsche M, Kamionka A, Hillen W, et al. (2007) Silencing Mycobacterium smegmatis by using tetracycline repressors. J Bacteriol 189: 4614-4623.